Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
VCV Digital Technology to Become Publicly Traded Via Business Combination with Fortune Rise Acquisition Corporation
-
VCV Digital Technology to Become Publicly Traded Via Business Combination with Fortune Rise Acquisition Corporation (FRLA)
-
VCV Digital Technology to Become Publicly Traded Via Business Combination with Fortune Rise Acquisition Corporation
-
ClimateRock (CLRCU) Prices 7.5M Unit IPO at $10/unit
-
ClimateRock Announces Pricing of $75.0 Million Initial Public Offering
-
ClimateRock Announces Pricing of $75.0 Million Initial Public Offering
-
Clarus Therapeutics Announces Closing of Upsized $30.0 Million Underwritten Public Offering
-
Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering
-
SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
-
Dermata Therapeutics Announces Closing of $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
-
Clarus Therapeutics (CRXT) Prices 26.68M Unit Offering at $1.10/unit
-
Clarus Therapeutics Announces Pricing of Upsized $30.0 Million Underwritten Public Offering
-
VerifyMe Acquires Assets of Logistics Management Company, PeriShip, LLC
-
SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities (LMAO)
-
SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities, Inc.
-
Scynexis (SCYX) Prices $45M Stock and Warrant Offering at $3/sh
-
SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
-
Aclarion, Inc. (ACON) Prices 2.165M Share IPO at $4.35/sh
-
Aclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public Offering
-
GiveMePower Corp Engages Maxim Group LLC to Provide Strategic Advisory and Investment Banking Services
-
GiveMePower Corp Engages Maxim Group LLC to Provide Strategic Advisory and Investment Banking Services
-
Dermata Therapeutics (DRMA) Announces $5 Million Private Placement of Common Stock, Warrants
-
Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
-
Saratoga Investment Corp. Prices Public Offering of $87.5 Million 6.00% Notes Due 2027
-
Saratoga Investment Corp. Prices Public Offering of $87.5 Million 6.00% Notes Due 2027
-
Sonic Foundry Announces Closing of $4.3 Million Public Offering
-
Sonic Foundry Announces Closing of $4.3 Million Public Offering
-
Maxim Group Starts Processa Pharmaceuticals (PCSA) at Buy
-
Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
VerifyMe Announces Closing of $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
-
Kraig Biocraft Laboratories Receives $1.5 Million in Capital Funding
-
Sonic Foundry (SOFO) Prices 1.7M Share Offering at $2.55/sh
-
Sonic Foundry Announces Pricing of $4.3 Million Public Offering
-
Sonic Foundry Announces Pricing of $4.3 Million Public Offering
-
Sonic Foundry (SOFO) Announces Proposed Public Offering of Common Stock
-
Sonic Foundry Announces Proposed Public Offering of Common Stock
-
Sonic Foundry Announces Proposed Public Offering of Common Stock
-
Joseph Gunnar Announces the Addition of Peter R. Serra to Lead its Investment Banking Group
-
InvestorNewsBreaks – Investor Summit Group, B2i Digital Inc. to Showcase Hand-Selected Presenting Companies at In-Person NYC Event
-
Fernhill Corp Provides Shareholder Update and Confirms the Company's 2022 Roadmap
-
Investor Summit Group Announces First Major In-Person Small-Cap & Microcap Conference to be Hosted in New York City Since Start of Pandemic
-
Why Psychedelics Could Soon Replace Antidepressants
-
VerifyMe Inc. (VRME) Announces 1.56M Share Private Placement at $3.21/sh
-
VerifyMe Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
-
Maxim Group LLC Announces Promotions within its Leadership
-
Iveda Announces Closing of $8.0 Million Public Offering Uplisting to Nasdaq and Reverse Stock Split
-
Iveda Announces Closing of $8.0 Million Public Offering Uplisting to Nasdaq and Reverse Stock Split
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC
-
Maxim: Society Pass (Nasdaq: SOPA) - 4Q21 Results and Outlook; Expansion Starts in the Attractive Southeast Asia Ecommerce Market

